Literature DB >> 29150837

Aprepitant improves refractory pruritus in primary cutaneous T-cell lymphomas: experience of the Spanish Working Group on Cutaneous Lymphomas.

L Maroñas-Jiménez1, T Estrach2, F Gallardo3, A Pérez4, H Andrés Borja5, O Servitje6, S Pérez Gala7, M Linares Barrio8, D Jiménez Gallo8, J Sanz-Bueno9, D Lora10, V Monsálvez1, P L Ortiz-Romero1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29150837     DOI： 10.1111/bjd.16128

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  3 in total

1.  Neurokinin 1 Receptor Antagonists for Pruritus.

Authors:  Majid Alam; Joerg Buddenkotte; Fareed Ahmad; Martin Steinhoff
Journal:  Drugs       Date:  2021-03-06       Impact factor: 9.546

Review 2.  NK-1 Receptor Antagonists and Pruritus: Review of Current Literature.

Authors:  Marcelina Pojawa-Gołąb; Kamila Jaworecka; Adam Reich
Journal:  Dermatol Ther (Heidelb)       Date:  2019-06-12

Review 3.  The changing therapeutic landscape, burden of disease, and unmet needs in patients with cutaneous T-cell lymphoma.

Authors:  Julia J Scarisbrick; Martine Bagot; Pablo L Ortiz-Romero
Journal:  Br J Haematol       Date:  2020-10-23       Impact factor: 6.998
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.